Fresenius Kabi signs exclusive U.S. distribution deal for Corvida Medical's HALO CSTD

Fresenius Kabi signed an exclusive U.S. distribution agreement with Corvida Medical for the HALO Closed System Drug-Transfer Device, enhancing its oncology care offerings.

“CSTDs play a critical role in protecting health care professionals from the risks of exposure to hazardous drugs during the preparation in the pharmacy and during patient administration by nurses.”businesswire.com

• 1 source
• businesswire.comFresenius Kabi Signs Exclusive U.S. Distribution Agreement with Corvida Medical for the HALO® Closed System Drug-Transfer DeviceMatt KuhnApr 1, 2021

Summarized from public sources; check the original articles before acting on it.